Abstract
Calciphylaxis is a rare disease characterized by ectopic calcification of skin arterioles resulting in ischemia, thrombosis and necrosis. Since end stage renal disease patients are those mainly affected, the term calcific uremic arteriolopathy (CUA) is also suggested. Early clinical manifestations are subtle, while overt necrotic ulcers may quickly spread and become infected so as to result in ominous outcome. Diagnosis might not be easy due to the number of other ischemic and non-ischemic skin lesions observed in uraemia. Skin biopsy, has been proposed as the diagnostic test and is often considered, but not systematically performed due to the hypothetical risk of further spreading of the lesions. Such ambiguity could be responsible for misdiagnosis or underdiagnosis. We review here five consecutive cases recorded in our Unit, all submitted to skin biopsy but with inconsistent results which generated some clinical frustration. Thus, we decided to carefully re-evaluate all of them together with pathologists and dermatologists. However, even after this ex-post discussion, we could not reach a complete agreement on the final diagnosis. In the meanwhile, papers were published in the literature that started to shed some light on the role of skin biopsy in the diagnosis of CUA.
References
McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McBane RD, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW (2016) Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc 91(10):1384–1394. https://doi.org/10.1016/j.mayocp.2016.06.025
Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE (2016) A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol 27(11):3421–3429
Hayashi M (2013) Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol 17(4):498–503. https://doi.org/10.1007/s10157-013-0782-z
Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, Schmitz S, Krüger T, Floege J, Ketteler M (2017) Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant 32(1):126–132. https://doi.org/10.1093/ndt/gfv438
Oliveira TM, Frazão JM (2015) Calciphylaxis: from the disease to the diseased. J Nephrol. 28(5):531–540. https://doi.org/10.1007/s40620-015-0192-2
Kramann R, Brandenburg VM, Schurgers LJ, Ketteler M, Westphal S, Leisten I, Bovi M, Jahnen-Dechent W, Knüchel R, Floege J, Schneider RK (2013) Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. Nephrol Dial Transplant 28(4):856–868. https://doi.org/10.1093/ndt/gfs466
Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI (2015) Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis 66(1):133–146. https://doi.org/10.1053/j.ajkd.2015.01.034
Brandenburg VM, Cozzolino M, Mazzaferro S (2014) Calcific uremic arteriolopathy: a call for action. Semin Nephrol 34(6):641–647. https://doi.org/10.1016/j.semnephrol.2014.09.007
Ellis CL, O’Neill WC (2018) Questionable specificity of histologic findings in calcific uremic arteriolopathy. Kidney Int 94(2):390–395. https://doi.org/10.1016/j.kint.2018.03.016
Williams EA, Moy AP, Cipriani NA, Nigwekar SU, Nazarian RM (2019) Factors associated with false-negative pathologic diagnosis of calciphylaxis. J Cutan Pathol 46(1):16–25. https://doi.org/10.1111/cup.13364
Nigwekar SU, Thadhani R, Brandenburg VM (2018) Calciphylaxis. N Engl J Med 378:1704–1714. https://doi.org/10.1056/nejmra1505292
Brandenburg VM, Evenepoel P, Floege J, Goldsmith D, Kramann R, Massy Z, Mazzaferro S, Schurgers LJ, Sinha S, Torregrosa V, Urena-Torres P, Vervloet M, Cozzolino M, Era-Edta Working Group on CKD-MBD Eucalnet (2016) Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? Nephrol Dial Transplant 31:1211–1219. https://doi.org/10.1093/ndt/gfw025
Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, Susantitaphong P (2019) Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep 4(2):231–244. https://doi.org/10.1016/j.ekir.2018.10.002
Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr (2013) Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol 8(7):1162–1170. https://doi.org/10.2215/cjn.09880912
Brandenburg V, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, Bahr D, Joubert PH, Salcedo C, Carroll KJ, Gold A, Perelló J (2019) Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J Nephrol. 32(5):811–821. https://doi.org/10.1007/s40620-019-00631-0
Pasquali M, De Martini N, Mazzaferro S (2019) Calciphylaxis: a conundrum for patients and nephrologists? J Nephrol. 32(5):677–680. https://doi.org/10.1007/s40620-019-00639-6
Brandenburg V, Adragao T, van Dam B, Evenepoel P, Frazão JM, Ketteler M, Mazzaferro S, Urena Torres P, Ramos R, Torregrosa JV, Cozzolino M (2015) Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet). Clin Kidney J 8(5):567–571. https://doi.org/10.1093/ckj/sfv056
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest for the current study.
Ethical standards
All the procedures involving humans in this study were in agreement with common and standard clinical practice and in accordance with institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rotondi, S., De Martini, N., Tartaglione, L. et al. On the role of skin biopsy in the diagnosis of calcific uremic arteriolopathy: a case-based discussion. J Nephrol 33, 859–865 (2020). https://doi.org/10.1007/s40620-019-00678-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-019-00678-z